Twist Bioscience Corporation Common Stock

TWSTNASDAQUSD
96.65 USD
5.30 (5.80%)AT CLOSE (11:59 AM EDT)
97.13
0.48 (0.50%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
97.13
0.48 (0.50%)
🔴Market: CLOSED

Twist Bioscience Corporation Common Stock (TWST) is currently trading at $96.67. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 25, 2026.

Open?$93.14
High?$98.40
Low?$91.88
Prev. Close?$91.35
Volume?2.8M
Avg. Volume?1.9M
VWAP?$95.85
Rel. Volume?1.48x
Bid / Ask
Bid?$96.00 × 100
Ask?$98.88 × 1.5K
Spread?$2.88
Midpoint?$97.44
Valuation & Ratios
Market Cap?5.7B
Shares Out?62.3M
Float?53.6M
Float %?86.1%
P/E Ratio?N/A
P/B Ratio?12.50
EPS?-$1.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Employees
979
Market Cap
5.7B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2018-10-31
Address
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO, CA 94080
Phone: 800-719-0671
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
31
Short Sent.?
21
Piotroski F-Score?3/9Weak
Altman Z-Score?12.84Safe
Confidence?56%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?32.95%Squeeze Risk
Short Interest?17.7M
Days to Cover?9.6
Free Float53.6M
Avg Daily Volume1.8M
Settlement Date2026-06-15
Financial Health
Current Ratio?2.70Strong
Quick Ratio?2.42Strong
Cash Ratio?1.02Strong
Debt/Equity?0.03Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A
P/B?
Peers
100
S&P
15
12.50HIGH
P/S?
Peers
100
S&P
3
13.89HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-52.2CHEAP
EV/Sales?
Peers
100
S&P
5
13.63HIGH
Returns & Efficiency
ROE?
S&P
8
-17.9%WEAK
ROA?
S&P
3
-12.0%WEAK
Cash Flow & Enterprise
FCF?$-100040000
Enterprise Value?$5.6B
Fundamentals ratios updated end of day